PharmaTher Holdings Cash Flow Statement

Financials in millions CAD. Fiscal year is June - May.

Millions CAD. Fiscal year is Jun - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021	2020
Net Income	-1.53	-3.12	-6.42	-4.01	2.66	Upgrade
Depreciation & Amortization	-	0	0	0	0	Upgrade
Loss (Gain) From Sale of Investments	0.02	0.22	2.63	0.13	0.9	Upgrade
Stock-Based Compensation	0.16	-	-	0.37	0.72	Upgrade
Other Operating Activities	-	-	0	-0.19	-3.54	Upgrade
Change in Accounts Receivable	0.01	0.03	-0.03	-0	-0.03	Upgrade
Change in Accounts Payable	0.11	-0.64	0.56	0.19	0.2	Upgrade
Change in Income Taxes	-	-	-	-0.04	0.04	Upgrade
Change in Other Net Operating Assets	0.02	-0.02	0.01	0.02	-0.03	Upgrade
Operating Cash Flow	-1.21	-3.52	-3.24	-3.51	0.92	Upgrade
Capital Expenditures	-	-	-	-	-0	Upgrade
Cash Acquisitions	-	-	-	-	0.22	Upgrade
Investment in Securities	-	-0.3	-	-	-	Upgrade
Investing Cash Flow	-	-0.3	-	-	0.21	Upgrade
Issuance of Common Stock	-	0.04	-	10.72	1.25	Upgrade
Other Financing Activities	-	-	-	-0.83	-	Upgrade
Financing Cash Flow	-	0.04	-	9.89	1.25	Upgrade
Net Cash Flow	-1.21	-3.79	-3.24	6.38	2.39	Upgrade
Free Cash Flow	-1.21	-3.52	-3.24	-3.51	0.92	Upgrade
Free Cash Flow Per Share	-0.01	-0.04	-0.04	-0.04	0.01	Upgrade
Levered Free Cash Flow	-0.65	-2.52	-1.93	-1.92	-1.01	Upgrade
Unlevered Free Cash Flow	-0.65	-2.52	-1.93	-1.92	-1.01	Upgrade
Change in Working Capital	0.14	-0.62	0.55	0.18	0.19	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.